TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer

Journal of Surgical Oncology

Volumn 109, Issue 3, 2014, Pages 189-197

  Shinmura, Kazuya ^a   Kiyose, Shinichiro ^a   Nagura, Kiyoko ^a   Igarashi, Hisaki ^a   Inoue, Yusuke ^a   Nakamura, Satoki ^a   Maeda, Matsuyoshi ^b   Baba, Megumi ^a   Konno, Hiroyuki ^a   Sugimura, Haruhiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

Author keywords

gastric cancer; gene amplification; prognostic marker; survival analysis; TNK2

Indexed keywords

EPHRIN RECEPTOR B3; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEMATOPOIETIC CELL KINASE; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR; TYROSINE KINASE AURKA; TYROSINE KINASE PTK7; TYROSINE KINASE TNK2; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE OVEREXPRESSION; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; STOMACH CANCER;

GASTRIC CANCER; GENE AMPLIFICATION; PROGNOSTIC MARKER; SURVIVAL ANALYSIS; TNK2;

AGED; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84893679655     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23482     Document Type: Article

References (44)

1. Manser E, Leung T, Salihuddin H, et al.: A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42. Nature 1993; 363: 364-367.
2. Mahajan K, Mahajan NP:, Shepherding AKT and androgen receptor by Ack1 tyrosine kinase. J Cell Physiol 2010; 224: 327-333.
3. Galisteo ML, Yang Y, Ureña J, et al.: Activation of the nonreceptor protein tyrosine kinase Ack by multiple extracellular stimuli. Proc Natl Acad Sci USA 2006; 103: 9796-9801.
4. Mahajan NP, Whang YE, Mohler JL, et al.: Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: Role of Ack1 in polyubiquitination of tumor suppressor Wwox. Cancer Res 2005; 65: 10514-10523.
5. Shen F, Lin Q, Gu Y, et al.: Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation. Mol Biol Cell 2007; 18: 732-742.
6. Pao-Chun L, Chan PM, Chan W, et al.: Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: An analysis of ACK1 effects on Axl signaling. J Biol Chem 2009; 284: 34954-34963.
7. Teo M, Tan L, Lim L, et al.: The tyrosine kinase ACK1 associates with clathrin-coated vesicles through a binding motif shared by arrestin and other adaptors. J Biol Chem 2001; 276: 18392-18398.
8. Mahajan NP, Liu Y, Majumder S, et al.: Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Proc Natl Acad Sci USA 2007; 104: 8438-8443.
9. Mahajan K, Coppola D, Challa S, et al.: Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation. PLoS ONE 2010; 5: e9646.
10. van der Horst EH, Degenhardt YY, Strelow A, et al.: Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. Proc Natl Acad Sci USA 2005; 102: 15901-15906.
11. Sugimura H, Mori H, Nagura K, et al.: Fluorescence in situ hybridization analysis with a tissue microarray: 'FISH and chips' analysis of pathology archives. Pathol Int 2010; 60: 543-550.
12. Kiyose S, Nagura K, Tao H, et al.: Detection of kinase amplifications in gastric cancer archives using fluorescence in situ hybridization. Pathol Int 2012; 62: 477-484.
13. Jehan Z, Bavi P, Sultana M, et al.: Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer. J Pathol 2009; 219: 337-346.
14. Jørgensen JT, Hersom M:, HER2 as a prognostic marker in gastric cancer-a systematic analysis of data from the literature. J Cancer 2012; 3: 137-144.
15. Grillo F, Fassan M, Ceccaroli C, et al.: The reliability of endoscopic biopsies in assessing HER2 status in gastric and gastroesophageal junction cancer: A study comparing biopsies with surgical samples. Transl Oncol 2013; 6: 10-16.
16. Kim HR, Kim DJ, Kang DR, et al.: Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer. J Clin Oncol 2013; 31: 731-737.
17. Shinmura K, Goto M, Suzuki M, et al.: Reduced expression of MUTYH with suppressive activity against mutations caused by 8-hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer. J Pathol 2011; 225: 414-423.
18. Prieto-Echagüe V, Gucwa A, Brown DA, et al.: Regulation of Ack1 localization and activity by the amino-terminal SAM domain. BMC Biochem 2010; 11: 42.
19. Shinmura K, Bennett RA, Tarapore P, et al.: Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication. Oncogene 2007; 26: 2939-2944.
20. Dahlquist KD, Salomonis N, Vranizan K, et al.: GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 2002; 31: 19-20.
21. Mahajan K, Challa S, Coppola D, et al.: Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity. Prostate 2010; 70: 1274-1285.
22. Mahajan K, Coppola D, Chen YA, et al.: Ack1 tyrosine kinase activation correlates with pancreatic cancer progression. Am J Pathol 2012; 180: 1386-1393.
23. Ding S, Wu X, Li G, et al.: Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 2005; 122: 473-483.
24. Qiu MZ, Cai MY, Zhang DS, et al.: Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China. J Transl Med 2013; 11: 58.
25. Howlin J, Rosenkvist J, Andersson T:, TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells. Breast Cancer Res 2008; 10: R36.
26. Liu Z, Adams HC III, Whitehead IP:, The rho-specific guanine nucleotide exchange factor Dbs regulates breast cancer cell migration. J Biol Chem 2009; 284: 15771-15780.
27. Chua BT, Lim SJ, Tham SC, et al.: Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells. Mol Oncol 2010; 4: 323-334.
28. Santarpia L, Lippman SM, El-Naggar AK:, Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets 2012; 16: 103-119.
29. Lee J, Kim S, Kim P, et al.: A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers. PLoS ONE 2013; 8: e54644.
30. Achyut BR, Yang L:, Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology 2011; 141: 1167-1178.
31. Arora S, Gonzales IM, Hagelstrom RT, et al.: RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma. Mol Cancer 2010; 9: 218.
32. Liu Y, Karaca M, Zhang Z, et al.: Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases. Oncogene 2010; 29: 3208-3216.
33. Sen S, Zhou H, Zhang RD, et al.: Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 2002; 94: 1320-1329.
34. Jeng YM, Peng SY, Lin CY, et al.: Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 2004; 10: 2065-2071.
35. Reiter R, Gais P, Jütting U, et al.: Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin Cancer Res 2006; 12: 5136-5141.
36. Yang F, Guo X, Yang G, et al.: AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma. Mod Pathol 2011; 24: 836-845.
37. Siggelkow W, Boehm D, Gebhard S, et al.: Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients. BMC Cancer 2012; 12: 562.
38. Lens SM, Voest EE, Medema RH:, Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 2010; 10: 825-841.
39. Macdonald J, Taylor L, Sherman A, et al.: Efficient genetic modification and germ-line transmission of primordial germ cells using piggyBac and Tol2 transposons. Proc Natl Acad Sci USA 2012; 109: E1466-E1472.
40. Cary LC, Goebel M, Corsaro BG, et al.: Transposon mutagenesis of baculoviruses: Analysis of Trichoplusia ni transposon IFP2 insertions within the FP-locus of nuclear polyhedrosis viruses. Virology 1989; 172: 156-169.
41. Breccia M, Salaroli A, Molica M, et al.: Systematic review of dasatinib in chronic myeloid leukemia. Onco Targets Ther 2013; 6: 257-265.
42. Yonemori K, Tsuta K, Shimizu C, et al.: Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy. J Surg Oncol 2010; 101: 222-227.
43. Lee CK, Brown C, Gralla RJ, et al.: Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: A meta-analysis. J Natl Cancer Inst 2013; 105: 595-605.
44. Jiao X, Kopecky DJ, Liu J, et al.: Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4- amines as ACK1 inhibitors. Bioorg Med Chem Lett 2012; 22: 6212-6217.